Arbutus Biopharma Corp
ABUS
Revenue
0.00
0.000.00%
-Assets
71.72M
▲19.12M▲36.35%
12 Months ChangeLiabilities
12.52M
▲846.10k▲7.25%
12 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 8-K
ID: 0001171843-24-005618
2024-10-11
Form 8-K
ID: 0001447028-24-000084
2024-08-08
Form 10-Q
ID: 0001447028-24-000072
2024-08-05
Form 8-K
ID: 0001447028-24-000066
2024-08-01
Form 8-K
ID: 0001171843-24-004324
2024-06-06
Form 8-K
ID: 0001171843-24-003323
2024-06-05
Form 8-K
ID: 0001171843-24-003302
2024-05-28
Form 8-K
ID: 0001447028-24-000061
2024-05-22
Form 8-K
ID: 0001171843-24-003042
2024-05-02
Form 10-Q
ID: 0001447028-24-000038